A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis. (Record no. 23552943)

MARC details
000 -LEADER
fixed length control field 01483 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516195551.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201502s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1432-1459
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s00415-014-7264-4
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Vollmer, T L
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150202
245 00 - TITLE STATEMENT
Title A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of neurology
Date of publication, distribution, etc. Apr 2014
300 ## - PHYSICAL DESCRIPTION
Extent 773-83 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Endpoint Determination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon-beta
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multiple Sclerosis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinolones
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recurrence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Assessment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sorensen, P S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Selmaj, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zipp, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Havrdova, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cohen, J A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sasson, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gilgun-Sherki, Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arnold, D L
773 0# - HOST ITEM ENTRY
Title Journal of neurology
Related parts vol. 261
-- no. 4
-- p. 773-83
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s00415-014-7264-4">https://doi.org/10.1007/s00415-014-7264-4</a>
Public note Available from publisher's website

No items available.